Effects of Wenyangbushen formula on the expression of VEGF, OPG, RANK and RANKL in rabbits with steroid-induced femoral head avascular necrosis.

The present study aimed to investigate the effects of Wenyangbushen formula on the mRNA and protein expression levels of vascular endothelial growth factor (VEGF), osteoprotegerin (OPG), receptor activator of nuclear factor (NF)‑κβ ligand (RANK), and RANK ligand (RANKL) in a rabbit model of steroid‑induced avascular necrosis of the femoral head (SANFH). The present study also aimed to examine the potential mechanism underlying the effect of this formula on the treatment of SANFH. A total of 136 New Zealand rabbits were randomly divided into five groups: Normal group, model group, and three groups treated with the traditional Chinese medicine (TCM), Wenyangbushen decoction, at a low, moderate and high dose, respectively. The normal group and positive control group were intragastrically administered with saline. The TCM groups were treated with Wenyangbushen decoction at the indicated dosage. Following treatment for 8 weeks, the mRNA and protein expression levels of VEGF, OPG, RANK and RANKL in the femoral head tissues were determined using reverse transcription‑quantitative polymerase chain reaction and western blot analyses, respectively. The data revealed that Wenyangbushen decoction effectively promoted the growth of bone cells, osteoblasts and chondrocytes, and prevented cell apoptosis in the SANFH. The mRNA and protein expression levels of OPG and VEGF were increased, while the levels of RANK and RANKL were reduced in the necrotic tissue of the model group, compared with those in the normal rabbits. Wenyangbushen treatment prevented these changes, manifested by an upregulation in the expression levels of VEGF and OPG, and downregulation in the expression levels of RANK and RANKL in a dose‑dependent manner. It was concluded that treatment with Wenyangbushen formula alleviated necrosis of the femoral head induced by steroids. It was observed to promote bone cell, osteoblast and chondrocyte growth, as well as prevent cell apoptosis. In addition, it upregulated the expression levels of OPG and VEGF, and inhibited the expression levels of RANK and RANKL. These results suggest the potential use of Wenyangbushen formula as a possible approach for the effective treatment of SANFH.

[1]  Jiumao Lin,et al.  Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo , 2015, Molecular medicine reports.

[2]  Renhui Liu,et al.  Effect of the Combined Extracts of Herba Epimedii and Fructus Ligustri Lucidi on Sex Hormone Functional Levels in Osteoporosis Rats , 2015, Evidence-based complementary and alternative medicine : eCAM.

[3]  T. Pufe,et al.  Enoxaparin Prevents Steroid-Related Avascular Necrosis of the Femoral Head , 2014, TheScientificWorldJournal.

[4]  L. Qin,et al.  Pathomorphological changes of bone marrow adipocytes in process of steroid-associated osteonecrosis. , 2013, International journal of clinical and experimental pathology.

[5]  Q. Cui,et al.  The Pathogenesis of Nontraumatic Osteonecrosis , 2012, Arthritis.

[6]  P. Geusens.  The role of RANK ligand/osteoprotegerin in rheumatoid arthritis , 2012, Therapeutic advances in musculoskeletal disease.

[7]  Yeong-Wook Song,et al.  Vascular endothelial growth factor polymorphisms in patients with steroid‐induced femoral head osteonecrosis , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[8]  Letian Shan,et al.  Gene Expression Profile of Steroid-induced Necrosis of Femoral Head of Rats , 2011, Calcified Tissue International.

[9]  Wei-Heng Chen,et al.  [Experimental research progress of warming yang and reinforcing kidney of Chinese medicine to promote the differentiation of bone marrow stromal cells]. , 2011, Zhongguo gu shang = China journal of orthopaedics and traumatology.

[10]  Y. Sun,et al.  Changes in Femoral Head Blood Supply and Vascular Endothelial Growth Factor in Rabbits with Steroid-induced Osteonecrosis , 2010, The Journal of international medical research.

[11]  H. Gill,et al.  Avascular necrosis associated with fracture of the femoral neck after hip resurfacing: histological assessment of femoral bone from retrieval specimens. , 2010, The Journal of bone and joint surgery. British volume.

[12]  T. Pufe,et al.  Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head , 2009, Clinical orthopaedics and related research.

[13]  M. Glimcher,et al.  The effects of alendronate in the treatment of experimental osteonecrosis of the hip in adult rabbits. , 2009, Osteoarthritis and cartilage.

[14]  M. Relling,et al.  A mouse model for glucocorticoid‐induced osteonecrosis: Effect of a steroid holiday , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[15]  Yu-Di Bai,et al.  Inhibition of RANK/RANKL signal transduction pathway: a promising approach for osteoporosis treatment. , 2008, Medical hypotheses.

[16]  L. Xing,et al.  Functions of RANKL/RANK/OPG in bone modeling and remodeling. , 2008, Archives of biochemistry and biophysics.

[17]  L. Xing,et al.  The RANKL/RANK/OPG pathway , 2007, Current osteoporosis reports.

[18]  T. Beyzadeoglu,et al.  [The effect of steroid use on the pathogenesis of avascular necrosis of the femoral head: an animal model]. , 2007, Acta orthopaedica et traumatologica turcica.

[19]  P. Kostenuik,et al.  RANKL Inhibition: A Novel Strategy to Decrease Femoral Head Deformity After Ischemic Osteonecrosis , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  S. Théoleyre,et al.  Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities. , 2004, Experimental cell research.

[21]  S. Santavirta,et al.  Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. , 2003, The Journal of bone and joint surgery. British volume.

[22]  M. Takami,et al.  Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin , 2002, The Anatomical record.

[23]  John C. Lee,et al.  Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells , 1999, Molecular and Cellular Endocrinology.

[24]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.